32.68
前日終値:
$34.15
開ける:
$33.89
24時間の取引高:
697.40K
Relative Volume:
0.49
時価総額:
$2.57B
収益:
$399.58M
当期純損益:
$-54.04M
株価収益率:
-43.57
EPS:
-0.75
ネットキャッシュフロー:
$40.13M
1週間 パフォーマンス:
+2.67%
1か月 パフォーマンス:
+5.42%
6か月 パフォーマンス:
-1.45%
1年 パフォーマンス:
-3.11%
Veracyte Inc Stock (VCYT) Company Profile
名前
Veracyte Inc
セクター
電話
(650) 243-6300
住所
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
VCYT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
VCYT
Veracyte Inc
|
32.68 | 2.69B | 399.58M | -54.04M | 40.13M | -0.75 |
![]()
TMO
Thermo Fisher Scientific Inc
|
468.00 | 177.38B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
185.91 | 135.85B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
627.17 | 51.87B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
124.38 | 35.70B | 6.79B | 1.22B | 1.09B | 4.26 |
![]()
IQV
Iqvia Holdings Inc
|
181.24 | 31.70B | 15.70B | 1.24B | 2.01B | 6.91 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-20 | 開始されました | Craig Hallum | Buy |
2024-12-05 | ダウングレード | Goldman | Buy → Neutral |
2024-11-15 | 開始されました | Wolfe Research | Outperform |
2024-10-16 | 開始されました | UBS | Buy |
2024-10-10 | 開始されました | Guggenheim | Buy |
2024-02-23 | 繰り返されました | Needham | Buy |
2023-01-18 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
2022-01-07 | 開始されました | Stephens | Overweight |
2021-11-18 | 再開されました | Goldman | Buy |
2021-06-15 | 開始されました | Raymond James | Outperform |
2021-02-18 | 再開されました | Needham | Buy |
2021-01-28 | 開始されました | Truist | Buy |
2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
2020-09-09 | 開始されました | Morgan Stanley | Underweight |
2019-07-31 | 開始されました | Lake Street | Buy |
2019-07-02 | 開始されました | Needham | Buy |
2018-11-29 | ダウングレード | Janney | Buy → Neutral |
2018-10-31 | アップグレード | Janney | Neutral → Buy |
2017-11-07 | ダウングレード | Janney | Buy → Neutral |
2017-11-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
2017-08-31 | 再開されました | BTIG Research | Buy |
2016-11-14 | 再開されました | Leerink Partners | Outperform |
2015-12-18 | 開始されました | Cantor Fitzgerald | Buy |
2015-06-11 | 繰り返されました | Leerink Partners | Outperform |
2013-11-26 | 開始されました | William Blair | Outperform |
すべてを表示
Veracyte Inc (VCYT) 最新ニュース
Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025 - BioSpace
Veracyte to present first prospective data on hormone therapy biomarker By Investing.com - Investing.com South Africa
Veracyte, Inc. Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented At Astro 2025 - MarketScreener
First-Ever Hormone Therapy Response Predictor: Veracyte's Groundbreaking Prostate Cancer Study at ASTRO 2025 - Stock Titan
Strs Ohio Makes New Investment in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (NASDAQ:VCYT) SVP Annie Mcguire Sells 2,283 Shares - MarketBeat
Exchange Traded Concepts LLC Purchases 23,047 Shares of Veracyte, Inc. $VCYT - MarketBeat
Assenagon Asset Management S.A. Increases Stake in Veracyte, Inc. $VCYT - MarketBeat
Price Action: Can 374Water Inc be recession proofMarket Activity Report & Safe Entry Momentum Stock Tips - خودرو بانک
Short Covering: What is the dividend yield of Veracyte IncTrade Entry Report & Smart Investment Allocation Insights - خودرو بانک
Market Rankings: What is the Moat Score of AMN Healthcare Services IncSwing Trade & Daily Technical Forecast Reports - خودرو بانک
Market Trends: Is Veracyte Incs ROIC above industry averageEarnings Recap Summary & Free Real-Time Volume Trigger Notifications - خودرو بانک
Aug Intraday: Is Veracyte Inc a strong candidate for buy and holdJuly 2025 Closing Moves & Stepwise Swing Trade Plans - خودرو بانک
Is Veracyte Inc. trending in predictive chart modelsJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com
Can momentum traders help lift Veracyte Inc.Market Volume Summary & Consistent Return Investment Signals - newser.com
Aug Summary: Is Ondas Holdings Inc forming a bullish divergenceEarnings Risk Report & Verified Technical Trade Signals - khodrobank.com
AQR Capital Management LLC Sells 34,410 Shares of Veracyte, Inc. $VCYT - MarketBeat
RSI Check: Is Veracyte Inc. a turnaround storyJuly 2025 Trade Ideas & Risk Controlled Daily Trade Plans - khodrobank.com
Is Veracyte Incs ROIC above industry average2025 Earnings Impact & Stepwise Trade Signal Guides - خودرو بانک
Exit strategy if you’re trapped in Veracyte Inc.Portfolio Return Summary & Safe Entry Momentum Tips - newser.com
Day Trade: Should I buy SPYU stock nowNew Guidance & Consistent Growth Stock Picks - خودرو بانک
Great Lakes Advisors LLC Sells 21,107 Shares of Veracyte, Inc. $VCYT - MarketBeat
Growth Report: Can Traeger Inc disrupt its industryTrade Performance Summary & Low Drawdown Trading Strategies - خودرو بانک
MACD Signal: Is Veracyte Inc a strong candidate for buy and holdMarket Trend Report & Intraday High Probability Alerts - خودرو بانک
Aug Patterns: What are the future prospects of Veracyte IncWeekly Gains Summary & Verified Momentum Watchlists - خودرو بانک
Whale Trades: Can Peoples Financial Services Corp. ride the EV wave2025 Retail Activity & Smart Allocation Stock Tips - خودرو بانک
Does Veracyte Inc. fit your quant trading modelMarket Volume Report & Risk Adjusted Swing Trade Ideas - newser.com
AQR Capital Management LLC Lowers Stock Position in Veracyte, Inc. $VCYT - Defense World
Veracyte (NASDAQ:VCYT) CEO Marc Stapley Sells 7,667 Shares - MarketBeat
Is Veracyte Inc. still worth holding after the dip2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
Can trapped investors hope for a rebound in Veracyte Inc.Trade Entry Summary & Low Risk Entry Point Tips - Newser
Will Veracyte Inc. stock go up soonQuarterly Trade Summary & High Yield Stock Recommendations - Newser
Real time scanner hits for Veracyte Inc. explainedEntry Point & Low Risk Entry Point Tips - Newser
Tools to monitor Veracyte Inc. recovery probabilityJuly 2025 Trends & Risk Managed Investment Signals - Newser
Price momentum metrics for Veracyte Inc. explainedQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Will earnings trigger a reversal in Veracyte Inc.July 2025 WrapUp & Free Daily Entry Point Trade Alerts - Newser
Bridgeway Capital Management LLC Sells 41,300 Shares of Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. $VCYT Shares Purchased by Parkman Healthcare Partners LLC - MarketBeat
Veracyte (VCYT) Valuation in Focus as Groundbreaking Prostate Cancer Study Drives Clinical Adoption and Pipeline Progress - Sahm
Veracyte at Morgan Stanley Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa
Transcript : Veracyte, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 04 - MarketScreener
Veracyte at Morgan Stanley Conference: Strategic Growth and Innovation - Investing.com India
Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting - Business Wire
Veracyte CEO Stapley sells $233k in shares By Investing.com - Investing.com South Africa
Veracyte CEO Stapley sells $233k in shares - Investing.com India
Can Veracyte Inc. expand into new marketsWeekly Stock Report & Low Drawdown Momentum Trade Ideas - beatles.ru
Veracyte Inc (VCYT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):